{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T11:55:56Z","timestamp":1783511756466,"version":"3.55.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/PR39876\/BTIS\/137\/7\/2021"],"award-info":[{"award-number":["BT\/PR39876\/BTIS\/137\/7\/2021"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Graphics and Modelling"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jmgm.2026.109316","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T08:00:00Z","timestamp":1770364800000},"page":"109316","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Structural exploration of thiazole urea-based Gyr B inhibitors through different computational approaches: Bayesian classification, molecular docking and free energy-inspired molecular dynamics simulation"],"prefix":"10.1016","volume":"144","author":[{"given":"Yuvraj","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arijit","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Dogra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohan Lal","family":"Kori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Om","family":"Silakari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmgm.2026.109316_bib1","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.ijid.2021.02.107","article-title":"Global Tuberculosis Report 2020\u2013Reflections on the Global TB burden, treatment and prevention efforts","volume":"113","author":"Chakaya","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.jmgm.2026.109316_bib4","doi-asserted-by":"crossref","first-page":"203","DOI":"10.5005\/ijcdas-62-4-203","article-title":"National TB Elimination Programme\u2013Can it end TB in India by 2025: an appraisal","volume":"62","author":"Behera","year":"2020","journal-title":"Indian J. Chest Dis. Allied Sci."},{"issue":"11","key":"10.1016\/j.jmgm.2026.109316_bib5","first-page":"952","article-title":"Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months","volume":"6","author":"Nolan","year":"2002","journal-title":"Int. J. Tubercul. Lung Dis."},{"issue":"4","key":"10.1016\/j.jmgm.2026.109316_bib6","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S2213-2600(17)30079-6","article-title":"The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis","volume":"5","author":"Dheda","year":"2017","journal-title":"Lancet Respir. Med."},{"issue":"2","key":"10.1016\/j.jmgm.2026.109316_bib7","article-title":"Multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB) among children: where we stand now","volume":"15","author":"Chowdhury","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.jmgm.2026.109316_bib8","first-page":"142","article-title":"Fluoroquinolones for treating tuberculosis","volume":"9","author":"Kumar","year":"2017","journal-title":"Clin. Pharm."},{"issue":"11","key":"10.1016\/j.jmgm.2026.109316_bib9","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1021\/acs.biochem.4c00161","article-title":"Signal propagation in the ATPase domain of Mycobacterium tuberculosis DNA gyrase from dynamical-nonequilibrium molecular dynamics simulations","volume":"63","author":"Kamsri","year":"2024","journal-title":"Biochemistry"},{"issue":"4","key":"10.1016\/j.jmgm.2026.109316_bib10","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1128\/AAC.48.4.1281-1288.2004","article-title":"Mycobacterium tuberculosis DNA Gyr: interaction with quinolones and correlation with antimycobacterial drug activity","volume":"48","author":"Aubry","year":"2004","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"10","key":"10.1016\/j.jmgm.2026.109316_bib11","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.4155\/fmc-2017-0257","article-title":"Recent progress in the discovery and development of DNA Gyr B inhibitors","volume":"10","author":"Baran\u010dokov\u00e1","year":"2018","journal-title":"Future Med. Chem."},{"issue":"3-4","key":"10.1016\/j.jmgm.2026.109316_bib12","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3109\/10409239109114072","article-title":"DNA Gyr: structure and function","volume":"26","author":"Reece","year":"1991","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.jmgm.2026.109316_bib13","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.tube.2018.08.005","article-title":"In silico designing of domain B selective Gyr inhibitors for effective treatment of resistant tuberculosis","volume":"112","author":"Kashyap","year":"2018","journal-title":"Tuberculosis"},{"issue":"16","key":"10.1016\/j.jmgm.2026.109316_bib14","doi-asserted-by":"crossref","first-page":"7815","DOI":"10.1093\/nar\/gkt560","article-title":"Structural insight into negative DNA supercoiling by DNA Gyr, a bacterial type 2A DNA topoisomerase","volume":"41","author":"Papillon","year":"2013","journal-title":"Nucleic Acids Res."},{"issue":"3-4","key":"10.1016\/j.jmgm.2026.109316_bib15","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3109\/10409239109114072","article-title":"DNA Gyr: structure and function","volume":"26","author":"Reece","year":"1991","journal-title":"Critical reviews in biochemistry and molecular th"},{"issue":"5","key":"10.1016\/j.jmgm.2026.109316_bib16","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/nsmb.2278","article-title":"ATP binding controls distinct structural transitions of Escherichia coli DNA Gyr in complex with DNA","volume":"19","author":"Basu","year":"2012","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"27","key":"10.1016\/j.jmgm.2026.109316_bib17","doi-asserted-by":"crossref","first-page":"7929","DOI":"10.1021\/bi700789g","article-title":"Energy coupling in type II topoisomerases: why do they hydrolyze ATP?","volume":"46","author":"Bates","year":"2007","journal-title":"Biochemistry"},{"issue":"23","key":"10.1016\/j.jmgm.2026.109316_bib18","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1016\/j.jmb.2017.10.005","article-title":"Binding and hydrolysis of a single ATP is sufficient for N-gate closure and DNA supercoiling by Gyr","volume":"429","author":"Hartmann","year":"2017","journal-title":"J. Mol. Biol."},{"issue":"23","key":"10.1016\/j.jmgm.2026.109316_bib19","doi-asserted-by":"crossref","first-page":"5662","DOI":"10.3390\/molecules25235662","article-title":"Quinolones: mechanism, lethality and their contributions to antibiotic resistance","volume":"25","author":"Bush","year":"2020","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.jmgm.2026.109316_bib20","first-page":"43","article-title":"Study of mutations in the DNA Gyr gyrA gene of Escherichia coli","volume":"9","author":"Jaktaji","year":"2010","journal-title":"Iran. J. Pharm. Res. (IJPR): IJPR"},{"issue":"2","key":"10.1016\/j.jmgm.2026.109316_bib21","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/jac\/dkr449","article-title":"Evaluation of Gyr B as a drug target in Mycobacterium tuberculosis","volume":"67","author":"Chopra","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"10.1016\/j.jmgm.2026.109316_bib22","doi-asserted-by":"crossref","DOI":"10.1021\/id500013t","article-title":"A new-class antibacterial-almost. Lessons in drug discovery and development: A criaical analysis of more than 50 years of effort toward ATPase inhibitors of DNA Gyr and topoisomerase IV","volume":"1","author":"Bisacchi","year":"2015","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.jmgm.2026.109316_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103373","article-title":"Novel 2-arylbenzothiazole DNA Gyr inhibitors: synthesis, antimicrobial evaluation, QSAR and molecular docking studies","volume":"93","author":"Ghannam","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"9-10","key":"10.1016\/j.jmgm.2026.109316_bib24","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1515\/znc-2022-0002","article-title":"Synthesis, antimicrobial activity and modeling studies of thiazoles bearing pyridyl and triazolyl scaffolds","volume":"77","author":"Funda Tay","year":"2022","journal-title":"Z. Naturforsch. C Biosci."},{"issue":"23","key":"10.1016\/j.jmgm.2026.109316_bib25","doi-asserted-by":"crossref","first-page":"6552","DOI":"10.1016\/j.bmc.2014.10.016","article-title":"An efficient synthesis and biological screening of benzofuran and benzo [d] isothiazole derivatives for Mycobacterium tuberculosis DNA GyrB inhibition","volume":"22","author":"Reddy","year":"2014","journal-title":"Bioorg. Med. Chem."},{"issue":"2","key":"10.1016\/j.jmgm.2026.109316_bib26","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s11030-023-10612-y","article-title":"Design and synthesis of some novel hybrid molecules based on 4-thiazolidinone bearing pyridine-pyrazole scaffolds: molecular docking and molecular dynamics simulations of its major constituent onto DNA Gyr inhibition","volume":"28","author":"Desai","year":"2024","journal-title":"Mol. Divers."},{"issue":"8","key":"10.1016\/j.jmgm.2026.109316_bib27","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1007\/s00044-023-03077-z","article-title":"Recent insights into antibacterial potential of benzothiazole derivatives","volume":"32","author":"Kashyap","year":"2023","journal-title":"Med. Chem. Res."},{"issue":"1","key":"10.1016\/j.jmgm.2026.109316_bib28","doi-asserted-by":"crossref","first-page":"7846","DOI":"10.1038\/s41598-021-86424-7","article-title":"Design, synthesis and docking studies of novel thiazole derivatives incorporating pyridine moiety and assessment as antimicrobial agents","volume":"11","author":"Khidre","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jmgm.2026.109316_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103656","article-title":"Antimicrobial screening and pharmacokinetic profiling of novel phenyl-[1, 2, 4] triazolo [4, 3-a] quinoxaline analogues targeting DHFR and E. coli DNA Gyr B","volume":"96","author":"Omar","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.jmgm.2026.109316_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2020.107224","article-title":"Design of (quinolin-4-ylthio) carboxylic acids as new Escherichia coli DNA Gyr B inhibitors: machine learning studies, molecular docking, synthesis and biological testing","volume":"85","author":"Metelytsia","year":"2020","journal-title":"Comput. Biol. Chem."},{"issue":"7","key":"10.1016\/j.jmgm.2026.109316_bib31","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1016\/j.ejmech.2011.03.061","article-title":"Combining molecular docking and QSAR studies for modelling the antiGyr activity of cyclothialidine derivatives","volume":"46","author":"Sa\u00edz-Urra","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jmgm.2026.109316_bib32","article-title":"Identification of novel DNA Gyr inhibitor by combined Pharmacophore modeling, QSAR analysis, molecular docking, molecular dynamics, ADMET and DFT approaches","volume":"10","author":"Moulishankar","year":"2024","journal-title":"Acta Trop."},{"issue":"11","key":"10.1016\/j.jmgm.2026.109316_bib33","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1080\/1062936X.2019.1658218","article-title":"In silico study directed towards identification of the key structural features of GyrB inhibitors targeting MTB DNA Gyr: HQSAR, CoMSIA and molecular dynamics simulations","volume":"30","author":"Kamsri","year":"2019","journal-title":"SAR QSAR Environ. Res."},{"issue":"1","key":"10.1016\/j.jmgm.2026.109316_bib34","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbae696","article-title":"Machine learning\u2013enabled virtual screening indicates the anti-tuberculosis activity of aldoxorubicin and quarfloxin with verification by molecular docking, molecular dynamics simulations, and biological evaluations","volume":"26","author":"Zheng","year":"2025","journal-title":"Briefings Bioinf."},{"issue":"21","key":"10.1016\/j.jmgm.2026.109316_bib35","doi-asserted-by":"crossref","first-page":"8834","DOI":"10.1021\/jm401268f","article-title":"Thiazolopyridine ureas as novel antitubercular agents acting through inhibition of DNA Gyr B","volume":"56","author":"Kale","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2026.109316_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2022.105360","article-title":"A fragment-based structural analysis of MMP-2 inhibitors in search of meaningful structural fragments","volume":"144","author":"Banerjee","year":"2022","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.jmgm.2026.109316_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmgm.2023.108510","article-title":"Exploring structural requirements of HDAC10 inhibitors through comparative machine learning approaches","volume":"123","author":"Bhattacharya","year":"2023","journal-title":"J. Mol. Graph. Model."},{"issue":"4","key":"10.1016\/j.jmgm.2026.109316_bib38","article-title":"Quercetin and catechin assuage redox imbalance and neurochemical dysfunction in rotenone-induced neurotoxicity: a comparative in vivo experiment supported by in silico study","volume":"1","author":"Josiah","year":"2021","journal-title":"Phytomed. Plus"},{"issue":"26","key":"10.1016\/j.jmgm.2026.109316_bib39","doi-asserted-by":"crossref","first-page":"12339","DOI":"10.1039\/D3NJ01138K","article-title":"Identification of potential benzoxazolinones as CYP1B1 inhibitors via molecular docking, dynamics, waterswap, and in vitro analysis","volume":"47","author":"Raju","year":"2023","journal-title":"New J. Chem."},{"issue":"8","key":"10.1016\/j.jmgm.2026.109316_bib40","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1039\/D3MD00115F","article-title":"Design, synthesis and biological evaluation of phenanthridine amide and 1, 2, 3-triazole analogues against Mycobacterium tuberculosis","volume":"14","author":"Nandikolla","year":"2023","journal-title":"RSC Med. Chem."},{"issue":"3","key":"10.1016\/j.jmgm.2026.109316_bib41","doi-asserted-by":"crossref","first-page":"270","DOI":"10.2174\/0115734099282303240126061624","article-title":"Exploration of fingerprints and data mining-based prediction of some bioactive compounds from Allium sativum as histone deacetylase 9 (HDAC9) inhibitors","volume":"21","author":"Das","year":"2025","journal-title":"Curr. Comput. Aided Drug Des."},{"issue":"24","key":"10.1016\/j.jmgm.2026.109316_bib42","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1002\/jcc.26712","article-title":"Exploration of potential inhibitors for tuberculosis via structure\u2010based drug design, molecular docking, and molecular dynamics simulation studies","volume":"42","author":"Rajasekhar","year":"2021","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jmgm.2026.109316_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2020.107322","article-title":"Geo-Measures: a PyMOL plugin for protein structure ensembles analysis","volume":"87","author":"Kagami","year":"2020","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.jmgm.2026.109316_bib44","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jmgm.2017.03.002","article-title":"Molecular dynamics simulation studies of novel \u03b2-lactamase inhibitor","volume":"74","author":"Haq","year":"2017","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.jmgm.2026.109316_bib45","article-title":"Deciphering the structural attributes of PPAR-\u03b3 and SIRT1 to identify their dual activators using a combined molecular modeling approach","volume":"16","author":"Dogra","year":"2025","journal-title":"Biochim. Biophys. Acta Proteins Proteom."},{"key":"10.1016\/j.jmgm.2026.109316_bib46","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jmgm.2014.10.011","article-title":"Principal Component Analysis reveals correlation of cavities evolution and functional motions in proteins","volume":"55","author":"Desdouits","year":"2015","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.jmgm.2026.109316_bib47","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/978-1-62703-658-0_11","article-title":"Principal component analysis: a method for determining the essential dynamics of proteins","author":"David","year":"2014","journal-title":"Protein dynamics: Methods and protocols"},{"issue":"8","key":"10.1016\/j.jmgm.2026.109316_bib48","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jmgm.2009.01.006","article-title":"Free-energy landscape, principal component analysis, and structural clustering to identify representative conformations from molecular dynamics simulations: the myoglobin case","volume":"27","author":"Papaleo","year":"2009","journal-title":"J. Mol. Graph. Model."},{"issue":"10","key":"10.1016\/j.jmgm.2026.109316_bib49","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1080\/1062936X.2023.2261842","article-title":"Assessing structural insights into in-house arylsulfonyl L-(+) glutamine MMP-2 inhibitors as promising anticancer agents through structure-based computational modelling approaches","volume":"34","author":"Baidya","year":"2023","journal-title":"SAR QSAR Environ. Res."},{"key":"10.1016\/j.jmgm.2026.109316_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmgm.2023.108404","article-title":"Discovery of new inhibitors of Mycobacterium tuberculosis EPSP synthase-A computational study","volume":"121","author":"Dahmer","year":"2023","journal-title":"J. Mol. Graph. Model."},{"issue":"5","key":"10.1016\/j.jmgm.2026.109316_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0321500","article-title":"Unraveling potential EGFR kinase inhibitors: computational screening, molecular dynamics insights, and MMPBSA analysis for targeted cancer therapy development","volume":"20","author":"Khan","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.jmgm.2026.109316_bib52","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3389\/fmolb.2017.00087","article-title":"Recent developments and applications of the MMPBSA method","volume":"4","author":"Wang","year":"2018","journal-title":"Front. Mol. Biosci."},{"issue":"5","key":"10.1016\/j.jmgm.2026.109316_bib53","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expet Opin. Drug Discov."},{"issue":"7","key":"10.1016\/j.jmgm.2026.109316_bib54","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1021\/ci500020m","article-title":"G_mmpbsa- A GROMACS tool for high-throughput MM-PBSA calculations","volume":"54","author":"Kumari","year":"2014","journal-title":"J. Chem. Inf. Model."}],"container-title":["Journal of Molecular Graphics and Modelling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326326000422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326326000422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T08:16:32Z","timestamp":1772525792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1093326326000422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":52,"alternative-id":["S1093326326000422"],"URL":"https:\/\/doi.org\/10.1016\/j.jmgm.2026.109316","relation":{},"ISSN":["1093-3263"],"issn-type":[{"value":"1093-3263","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural exploration of thiazole urea-based Gyr B inhibitors through different computational approaches: Bayesian classification, molecular docking and free energy-inspired molecular dynamics simulation","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Graphics and Modelling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmgm.2026.109316","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109316"}}